No Data
No Data
TransCode Therapeutics Starts $10 Million Direct Offering of Stock, Warrants
Transcode Therapeutics: Gross Proceeds Expected to Be Approximately $10M >RNAZ
Transcode Therapeutics: Intends to Use Net Proceeds for Product Development Activities >RNAZ
Transcode Therapeutics: Offering Expected to Close March 25 >RNAZ
Express News | Transcode Therapeutics Inc - to Sell 10.25 Mln Shares and Warrants at $0.98 Each
Express News | Transcode Therapeutics, Inc. Announces Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Unlock the Full List